NSE and S100β in peripheral blood (PB) can provide valuable and timely diagnostic information for stroke, which is necessary for timely management and decision-making, and is conducive to clinical diagnosis and treatment guidance for stroke patients. This evidence concerns the gene S100B and stroke disorder.